Idiopathic acute pancreatitis

Journal of Clinical Gastroenterology

Volumn 37, Issue 3, 2003, Pages 238-250

  Kim, Hyun Jun ^a   Kim, Myung Hwan ^a   Bae, Jong Seok ^a   Lee, Sang Soo ^a   Seo, Dong Wan ^a   Lee, Sung Koo ^a  

^a NONE

Author keywords

Idiopathic; Pancreatitis

Indexed keywords

ACUTE PANCREATITIS; ALGORITHM; ANAMNESIS; BILE DUCT MALFORMATION; CFTR GENE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; PANCREAS DIVISUM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPINK 1 GENE; VATER PAPILLA STENOSIS;

ACUTE DISEASE; HUMANS; PANCREATITIS;

EID: 0041508600     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200309000-00010     Document Type: Review

References (173)

1. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med. 1994;330:1198-210.
2. Steer ML. Etiology and pathophysiology of acute pancreatitis. In: Go VLW, Gardner JD, Brooks FP, Lebenthal E, DiMagno EP, Scheele, GA. eds. The Exocrine Pancreas: Biology, Pathophysiology, and Diseases. New York: Raven Press, 1986:465-74.
3. Banks PA. Epidemiology, natural history, and predictors of disease outcome in acute and chronic pancreatitis. Gastrointest Endosc. 2002;56:226-30.
4. Tamasky PR, Hawes RH. Endoscopic diagnosis and therapy of unexplained (idiopathic) acute pancreatitis. Gastrointest Endosc Clin North Am. 1998;8:13-37.
5. Bank S, Indaram A. Causes of acute and recurrent pancreatitis: clinical considerations and clues to diagnosis. Gastroenterol Clin North Am. 1999;28:571-89.
6. Levy MJ, Geenen JE. Idiopathic acute recurrent pancreatitis. Am J Gastroenterol. 2001;96:2540-55.
7. Wilson C, Imrie CW, Carter DC. Fatal acute pancreatitis. Gut. 1988;29:782-8.
8. Banerjee AK, Kaul A, Bache E, et al. An audit of fatal acute pancreatitis. Postgrad Med J. 1995;71:472-5.
9. Venu RP, Geenen JE, Hogan W, et al. Idiopathic recurrent pancreatitis: an approach to diagnosis and treatment. Dig Dis Sci. 1989;34:56-60.
10. Bernard JP, Sahel J, Giovannini M, et al. Pancreas divisum is a probable cause of acute pancreatitis: a report of 137 cases. Pancreas. 1990;5:248-54.
11. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology. 2001;120:682-707.
12. Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Engl J Med. 1995;332:1482-90.
13. Jakobs R, Riemann JF. The role of endoscopy in acute recurrent and chronic pancreatitis and pancreatic cancer. Gastroenterol Clin North Am. 1999;28:783-800.
14. Somogyi L, Martin SP, Venkatesan T, et al. Recurrent acute pancreatitis: an algorithmic approach to identification and elimination of inciting factors. Gastroenterology. 2001;120:708-17.
15. Bradley EL III. Chronic obstructive pancreatitis as a delayed complication of pancreatic trauma. HPB Surg. 1991;5:49-59.
16. Tamasky PR, Hoffman B, Aabakken L, et al. Sphincter of Oddi dysfunction is associated with chronic pancreatitis. Am J Gastroenterol. 1997;92:1125-9.
17. Sakorafas GH, Tsiotou AG. Etiology and pathogenesis of acute pancreatitis: current concepts. J Clin Gastroenterol. 2000;30:343-56.
18. Soetikno RM, Carr-Locke DL. Endoscopic management of acute gallstone pancreatitis. Gastrointest Endosc Clin North Am. 1998;8:1-12.
19. Hernandez CA, Lerch MM. Sphincter stenosis and gallstone migration through the biliary tract. Lancet. 1993;341:1371-3.
20. Grendell JH. Acute pancreatitis. Clin Perspect Gastroenterol. 2000;3:327-31.
21. Fan ST, Lai EC, Mok FP, et al. Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med. 1993;328:228-32.
22. Steinberg WM, Neoptolemos JP, Fosch UR, et al. Controversies in clinical pancreatology: the management of severe gallstone pancreatitis. Pancreas. 2001;22:221-9.
23. Farinon AM, Ricci GL, Sianesi M, et al. Physiopathologic role of microlithiasis in gallstone pancreatitis. Surg Gynecol Obstet. 1987;164:252-6.
24. Levy MJ. The hunt for microlithiasis in idiopathic acute recurrent pancreatitis: should we abandon the search or intensify our efforts? Gastrointest Endosc. 2002;55:286-93.
25. Ko CW, Sekijima JH, Lee SP. Biliary sludge. Ann Intern Med. 1999;130:301-11.
26. Lee SP, Nicholls JF, Park HZ. Biliary sludge as a cause of acute pancreatitis. N Engl J Med. 1992;326:589-93.
27. Ros E, Navarro S, Bru C, et al. Occult microlithiasis in 'idiopathic' acute pancreatitis: prevention of relapses by cholecystectomy or ursodeoxycholic acid therapy. Gastroenterology. 1991;101:1701-9.
28. Kohut M, Nowak A, Nowakowska-Dulawa E, et al. The frequency of bile duct crystals in patients with presumed biliary pancreatitis. Gastrointest Endosc. 2001;54:37-41.
29. Juvonen T, Niemela O, Makela J, et al. Characteristics of symptomatic gallbladder disease in patients with either solitary or multiple cholesterol gallstones. Hepatogastroenterology. 1994;41:263-6.
30. Cooperberg PL, Burhenne HJ. Real-time ultrasonography. Diagnostic technique of choice in calculous gallbladder disease. N Engl J Med. 1980;302:1277-9.
31. McIntosh DM, Penney HF. Gray-scale ultrasonography as a screening procedure in the detection of gallbladder disease. Radiology. 1980;136:725-7.
32. Kurol M, Forsberg L. Ultrasonography in the diagnosis of acute cholecystitis. Acta Radiol Diagn (Stockh). 1984;25:379-83.
33. Eisen GM, Dominitz JA, Faigel DO, et al. An annotated algorithm for the evaluation of choledocholithiasis. Gastrointest Endosc. 2001;53:864-6.
34. Buscail L, Escourrou J, Delvaux M, et al. Microscopic examination of bile directly collected during endoscopic cannulation of the papilla: utility in patients with suspected microlithiasis. Dig Dis Sci. 1992;37:116-20.
35. Neoptolemos JP, Davidson BR, Winder AF, et al. Role of duodenal bile crystal analysis in the investigation of 'idiopathic' pancreatitis. Br J Surg. 1988;75:450-3.
36. Geenen JE, Nash JA. The role of sphincter of Oddi manometry and biliary microscopy in evaluating idiopathic recurrent pancreatitis. Endoscopy. 1998;30:237-41.
37. Quallich LG, Stern MA, Rich M, et al. Bile duct crystals do not contribute to sphincter of Oddi dysfunction. Gastrointest Endosc. 2002;55:163-6.
38. Allen B, Bernhoft R, Blanckaert N, et al. Sludge is calcium bilirubinate associated with bile stasis. Am J Surg. 1981;141:51-6.
39. Dahan P, Andant C, Levy P, et al. Prospective evaluation of endoscopic ultrasonography and microscopic examination of duodenal bile in the diagnosis of cholecystolithiasis in 45 patients with normal conventional ultrasonography. Gut. 1996;38:277-81.
40. Irani SK. Endoscopic management of pancreatic disorders. Gastroenterol Clin North Am. 1990;19:975-97.
41. Gregor JC, Ponich TP, Detsky AS. Should ERCP be routine after an episode of 'idiopathic' pancreatitis? A cost-utility analysis. Gastrointest Endosc. 1996;44:118-23.
42. Folsch UR, Nitsche R, Ludtke R, et al. Early ERCP and papillotomy compared with conservative treatment for acute biliary pancreatitis: the German Study Group on Acute Biliary Pancreatitis. N Engl J Med. 1997;336:237-42.
43. Corazziari E, Shaffer EA, Hogan WJ, et al. Functional disorders of the biliary tract and pancreas. Gut. 1999:45(suppl 2):48-54.
44. Chuttani R, Carr-Locke DL. Pathophysiology of the sphincter of Oddi. Surg Clin North Am. 1993;73:1311-22.
45. Kuo WH, Pasricha PJ, Kalloo AN. The role of sphincter of Oddi manometry in the diagnosis and therapy of pancreatic disease. Gastrointest Endosc Clin North Am. 1998;8:79-85.
46. Coyle W, Tarnasky P, Knapple W, et al. Evaluation of unexplained acute pancreatitis using ERCP, sphincter of Oddi manometry, and endoscopic ultrasound [Abstract]. Gastrointest Endosc. 1996;43:378.
47. Sherman S, Jamidar P, Reber H. Idiopathic acute pancreatitis: endoscopic approach to diagnosis and therapy [Abstract]. Am J Gastroenterol. 1993;88:1541.
48. Guelrud M, Mendoza S, Vlera L. Idiopathic recurrent pancreatitis and hypercontractile sphincter of Oddi: treatment with endoscopic sphincterotomy and pancreatic duct dilation [Abstract]. Gastroenterology. 1996;90:1443.
49. Wehrmann T, Zipf A, Caspary WF, et al. Sphincter of Oddi dysfunction in 'idiopathic' recurrent pancreatitis. Dtsch Med Wochenschr. 1996;121:781-7.
50. Aymerich RR, Prakash C, Aliperti G. Sphincter of oddi manometry: is it necessary to measure both biliary and pancreatic sphincter pressures? Gastrointest Endosc. 2000;52:183-6.
51. Eversman D, Fogel EL, Rusche M, et al. Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction. Gastrointest Endosc. 1999;50:637-41.
52. Sherman S, Troiano FP, Hawes RH, et al. Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter. Gastrointest Endosc. 1990;36:462-6.
53. Sherman S, Lehman GA. Endoscopic pancreatic sphincterotomy: techniques and complications. Gastrointest Endosc Clin North Am. 1998;8:115-24.
54. Fogel EL, Eversman D, Jamidar P, et al. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy. 2002;34:280-5.
55. Rabenstein T, Hahn EG. Post-ERCP pancreatitis: new momentum. Endoscopy. 2002;34:325-9.
56. Delhaye M, Engelholm L, Cremer M. Pancreas divisum: controversial clinical significance. Dig Dis. 1988;6:30-9.
57. Sahel J, Cros RC. Bourry J, et al. Clinico-pathological conditions associated with pancreas divisum. Digestion. 1982;23:1-8.
58. Baillie J. Pancreas divisum. Clin Perspect Gastroenterol. 2002;5:73-6.
59. Eisen G, Schutz S, Metzler D, et al. Santorinicele: new evidence for obstruction in pancreas divisum. Gastrointest Endosc. 1994;40:73-6.
60. Madura JA. Pancreas divisum: stenosis of the dorsally dominant pancreatic duct: a surgically correctable lesion. Am J Surg. 1986;151:742-5.
61. Kim MH, Lee SS, Kim CD, et al. Incomplete pancreas divisum: is it merely a normal anatomic variant without clinical implications? Endoscopy. 2001;33:778-85.
62. Warshaw AL, Simeone JF, Schapiro RH, et al. Evaluation and treatment of the dominant dorsal duct syndrome (pancreas divisum redefined). Am J Surg. 1990;159:59-64.
63. Warshaw AL, Simeone J, Schapiro RH, et al. Objective evaluation of ampullary stenosis with ultrasonography and pancreatic stimulation. Am J Surg. 1985;149:65-72.
64. Lowes JR, Lees WR, Cotton PB. Pancreatic duct dilatation after secretin stimulation in patients with pancreas divisum. Pancreas. 1989;4:371-4.
65. Costamagna G, Ingrosso M, Tringali A, et al. Santorinicele and recurrent acute pancreatitis in pancreas divisum: diagnosis with dynamic secretin-stimulated magnetic resonance pancreatography and endoscopic treatment. Gastrointest Endosc. 2000;52:262-7.
66. Jacob L, Geenen JE, Catalano MF, et al. Clinical presentation and short-term outcome of endoscopic therapy of patients with symptomatic incomplete pancreas divisum. Gastrointest Endosc. 1999;49:53-7.
67. Bret PM, Reinhold C, Taourel P, et al. Pancreas divisum: evaluation with MR cholangiopancreatography. Radiology. 1996;199:99-103.
68. Lehman GA, Sherman S. Diagnosis and therapy of pancreas divisum. Gastrointest Endosc Clin North Am. 1998;8:55-77.
69. Warshaw AL. Pancreas divisum - really. Surgery. 2000;128:832-3.
70. Whitcomb DC. Hereditary pancreatitis: new insights into acute and chronic pancreatitis. Gut. 1999;45:317-22.
71. Heyries L, Barthet M, Delvasto C, et al. Long-term results of endoscopic management of pancreas divisum with recurrent acute pancreatitis. Gastrointest Endosc. 2002;55:376-81.
72. Teich N, Bauer N, Mossner J, et al. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants. Am J Gastroenterol. 2002;97:341-6.
73. Teich N, Ockenga J, Keim V, et al. Genetic risk factors in chronic pancreatitis. J Gastroenterol. 2002;37:1-9.
74. Moss RB. New approaches to cystic fibrosis. Hosp Pract. 2001;36:25-7,31-2,35-7.
75. Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet. 2000;25:213-6.
76. Witt H, Hennies HC, Becker M. SPINK1 mutations in chronic pancreatitis. Gastroenterology. 2001;120:1060-1.
77. Pfizer RH, Barmada MM, Brunskill AP, et al. SPINK1/PST1 polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology. 2000;119:615-23.
78. Whitcomb DC. Genetic predispositions to acute and chronic pancreatitis. Med Clin North Am. 2000:84:531-47.
79. Comfort M, Steinberg A. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology. 1952;21:54-63.
80. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet. 1996;14:141-5.
81. Rinderknecht H. Pancreatic secretory enzymes. In: Go VLW, DiMagno EP, Gardner JD DiMagno EP, Gardner JD, et al. eds. The Pancreas: Biology, Pathobiology, and Disease. New York: Raven Press, 1993:219-51.
82. Sahin-Toth M, Graf L, Toth M. Trypsinogen stabilization by mutation Arg117→His: a unifying pathomechanism for hereditary pancreatitis? Biochem Biophys Res Commun. 1999;264:505-8.
83. Amann ST, Gates LK, Aston CE, et al. Expression and penetrance of the hereditary pancreatitis phenotype in monozygotic twins. Gut. 2001;48:542-7.
84. Sossenheimer MJ, Aston CE, Preston RA, et al. Clinical characteristics of hereditary pancreatitis in a large family, based on high-risk haplotype: the Midwest Multicenter Pancreatic Study Group (MMPSG). Am J Gastroenterol. 1997;92:1113-6.
85. Lowenfels AB, Maisonneuve P, DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cancer: International Hereditary Pancreatitis Study Group. J Natl Cancer lnst. 1997;89:442-6.
86. Fitz JG, Basavappa S, McGill J, et al. Regulation of membrane chloride currents in rat bile duct epithelial cells. J Clin Invest. 1993;91:319-28.
87. Cohn JA, Strong TV, Picciotto MR. et al. Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology. 1993;105:1857-64.
88. Tsui LC. The cystic fibrosis transmembrane conductance regulator gene. Am J Respir Crit Care Med. 1995;151(suppl):47-53.
89. Malats N, Casals T, Porta M, et al. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer: PANKRAS II Study Group. Gut. 2001;48:70-4.
90. Choudari CP, Lehman GA, Sherman S. Pancreatitis and cystic fibrosis gene mutations. Gastroenterol Clin North Am. 1999;28:543-9.
91. Cohn JA, Friedman KJ, Noone PG, et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med. 1998;339:653-8.
92. Kerem E, Corey M, Kerem BS, et al. The relation between genotype and phenotype in cystic fibrosis: analysis of the most common mutation (delta F508). N Engl J Med. 1990;323:1517-22.
93. Bishop MD, Ahmed N, Ellis L, et al. Cystic fibrosis genotype and phenotype testing in idiopathic chronic and recurrent acute pancreatitis [Abstract]. Pancreas. 1999;19:416.
94. Hoshina K, Kimura W, Ishiguro T, et al. Three generations of hereditary chronic pancreatitis. Hepatogastroenterology. 1999;46:1192-8.
95. DiMagno EP. Gene mutations and idiopathic chronic pancreatitis: clinical implications and testing. Gastroenterology. 2001;121:1508-12.
96. Grendell JH. Idiopathic acute pancreatitis. Gastroenterol Clin North Am. 1990;19:843-8.
97. Köhler H, Lankisch PG. Acute pancreatitis and hyperamylasaemia in pancreatic carcinoma. Pancreas. 1987;2:117-9.
98. Shemesh E, Czerniak A, Nass S, et al. Role of endoscopic retrograde cholangiopancreatography in differentiating pancreatic cancer coexisting with chronic pancreatitis. Cancer. 1990;65:893-6.
99. Kim HJ, Kim MH, Myung SJ, et al. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve. Am J Gastroenterol. 1999;94:1941-6.
100. Kim MH, Lee SK, Seo DW, et al. Tumors of the major duodenal papilla. Gastrointest Endosc. 2001;54:609-20.
101. Anderson JH, Morran CG, Anderson JR, et al. Acute pancreatitis and non-Hodgkin's lymphoma. Postgrad Med J. 1987;63:137-9.
102. Obara T, Shudo R, Fujii T, et al. Pancreatic duct obstruction caused by malignant islet cell tumors of the pancreas. Gastrointest Endosc. 2000;51:604-7.
103. McLatchie GR, Imrie CW. Acute pancreatitis associated with tumour metastases in the pancreas. Digestion. 1981;21:13-7.
104. Niijima M, Yamaguchi T, Ishihara T, et al. Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas. Cancer. 2002;94:1565-73.
105. Yamaguchi K, Tanaka M. Intraductal papillary-mucinous tumor of the pancreas: a historical review of the nomenclature and recent controversy. Pancreas. 2001;23:12-9.
106. Hara T, Yamaguchi T, Ishihara T, et al. Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonography. Gastroenterology. 2002;122:34-43.
107. Farrel JJ, Brugge WR. Intraductal papillary mucinous tumor of the pancreas. Gastrointest Endosc. 2002;55:701-14.
108. Azar C, Van de Stadt J, Rickaert F, et al. Intraductal papillary mucinous tumours of the pancreas: clinical and therapeutic issues in 32 patients. Gut. 1996;39:457-64.
109. Klöppel G. Clinicopathologic view of intraductal papillary-mucinous tumor of the pancreas. Hepatogastroenterology. 1998;45:1981-5.
110. Seo DW, Kim MH, Lee SK, et al. The value of pancreatoscopy in patients with mucinous ductal ectasia. Endoscopy. 1997;29:315-8.
111. Azar C, Van de Stadt J, Rickaert F, et al. Intraductal papillary mucinous tumours of the pancreas: clinical and therapeutic issues in 32 patients. Gut. 1996;39:457-64.
112. Sugiura H, Kondo S, Islam HK, et al. Clinicopathologic features and outcomes of intraductal papillary-mucinous tumors of the pancreas. Hepatogastroenterology. 2002;49:263-7.
113. Guelrud M, Morera C, Rodriguez M, et al. Normal and anomalous pancreaticobiliary union in children and adolescents. Gastrointest Endosc. 1999;50:189-93.
114. Okada A, Nakamura T, Higaki J, et al. Congenital dilatation of the bile duct in 100 instances and its relationship with anomalous junction. Surg Gynecol Obstet. 1990;171:291-8.
115. Matsumoto Y, Fujii H, Itakura J, et al. Recent advances in pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg. 2002;9:45-54.
116. Komi N, Takehara H, Kunitomo K, et al. Does the type of anomalous arrangement of pancreaticobiliary ducts influence the surgery and prognosis of choledochal cyst? J Pediatr Surg. 1992;27:728-31.
117. Japanese Study Group on Pancreaticobiliary Maljunction. Diagnostic criteria of pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg. 1994;1:219-21.
118. Guelrud M, Morera C, Rodriguez M, et al. Sphincter of Oddi dysfunction in children with recurrent pancreatitis and anomalous pancreaticobiliary union: an etiologic concept. Gastrointest Endosc. 1999;50:194-9.
119. Samavedy R, Sherman S, Lehman GA. Endoscopic therapy in anomalous pancreatobiliary duct junction. Gastrointest Endosc. 1999;50:623-7.
120. Nomura T, Shirai Y, Sandoh N, et al. Cholangiographic criteria for anomalous union of the pancreatic and biliary ducts. Gastrointest Endosc. 2002;55:204-8.
121. Kinoshita H, Nagata E, Hirohashi K, et al. Carcinoma of the gallbladder with an anomalous connection between the choledochus and the pancreatic duct: report of 10 cases and review of the literature in Japan. Cancer. 1984;54:762-9.
122. Davenport M, Stringer MD, Howard ER. Biliary amylase and congenital choledochal dilatation. J Pediatr Surg. 1995;30:474-7.
123. Yamaguchi S, Koga A, Matsumoto S, et al. Anomalous junction of pancreaticobiliary duct without congenital choledochal cyst: a possible risk factor for gallbladder cancer. Am J Gastroenterol. 1987;82:20-4.
124. Sandoh N, Shirai Y, Hatakeyama K. Incidence of anomalous union of the pancreaticobiliary ductal system in biliary cancer. Hepatogastroenterology. 1997;44:1580-3.
125. Matsumoto Y, Fujii H, Itakura J, et al. Pancreaticobiliary maljunction: etiologic concepts based on radiologic aspects. Gastrointest Endosc. 2001;53:614-9.
126. Chijiwa K, Kimura H, Tanaka M. Malignant potential of the gallbladder in patients with anomalous pancreaticobiliary ductal junction: the difference in risk between patients with and without choledochal cyst. Int Surg. 1995;80:61-4.
127. Hasumi A, Sugatani H, Aoki H. Pancreatobiliary maljunction and bile duct cancer [in Japanese]. Tan Sui. 1995;16:753-7.
128. Hara H, Morita S, Ishibashi T, et al. Studies on biliary tract carcinoma in the case with pancreaticobiliary maljunction. Hepatogastroenterology. 2002;49:104-8.
129. Todani T, Watanabe Y, Narusue M, et al. Congenital bile duct cysts: classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg. 1977;134:263-9.
130. Sarris GE, Tsang D. Choledochocele: case report, literature review, and a proposed classification. Surgery. 1989;105:408-14.
131. Kim MH, Myung SJ, Lee SK, et al. Ballooning of the papilla during contrast injection: the semaphore of a choledochocele. Gastrointest Endosc. 1998;48:258-62.
132. Goldberg PB, Long WB, Oleaga JA, et al. Choledochocele as a cause of recurrent pancreatitis. Gastroenrerology. 1980;78:1041-5.
133. Gerritsen JJ, Janssens AR, Kroon HM. Choledochocele: treatment by endoscopic sphincterotomy. Br J Surg. 1988;75:495-6.
134. Ozawa K, Yamada T, Matumoto Y, et al. Carcinoma arising in a choledochocele. Cancer. 1980;45:195-7.
135. Schulte SJ. Embryology, and congenital anomalies of the bile and pancreatic ducts. In: Silvis S, Rohrmann CA, Ansel HJ. eds. Text and Atlas of Endoscopic Retrograde Cholangiopancreatography. New York: Igaku-Shoin, 1995:114-45.
136. Itoh Y, Hada T, Terano A, et al. Pancreatitis in the annulus of annular pancreas demonstrated by the combined use of computed tomography and endoscopic retrograde chelangiopancreatography. Am J Gastroenterol. 1989;84:961-4.
137. Rizzo RJ, Szucs RA, Turner MA. Congenital abnormalities of the pancreas and biliary tree in adults. Radiographics. 1995;15:49-68.
138. Lehman GA, O'Connor KW. Coexistence of annular pancreas and pancreas divisum: ERCP diagnosis. Gastrointest Endosc. 1985;31:25-8.
139. Ravitch MM. The pancreas in infants and children. Surg Clin North Am. 1975;55:377-85.
140. Horiuchi A, Kawa S, Hamano H, et al. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc. 2002;55:494-9.
141. Kim HS, Lee DK, Kim IW, et al. The role of endoscopic retrograde pancreatography in the treatment of traumatic pancreatic duct injury. Gastrointest Endosc. 2001;54:49-55.
142. Khuroo MS, Zargar SA, Yattoo GN, et al. Ascaris-induced acute pancreatitis. Br J Surg. 1992;79:1335-8.
143. Sarles H, Sarles JC, Muratore R, et al. Chronic inflammatory sclerosis of the pancreas: an autonomous pancreatic disease? Am J Dig Dis. 1991;6:688-98.
144. Kim JY, Chang HS, Kim MH, et al. A case of autoimmune chronic pancreatitis improved with oral steroid therapy. Korean J Gastroenterol. 2002;39:304-8.
145. Ballinger AB, Barnes E, Alstead EM, et al. Is intervention necessary after a first episode of acute idiopathic pancreatitis? Gut. 1996;38:293-5.
146. Feller ER. Endoscopic retrograde cholangiopancreatography in the diagnosis of unexplained pancreatitis. Arch Intern Med. 1984;144:1797-9.
147. Kaw M, Brodmerkel GJ Jr. ERCP, biliary crystal analysis, and sphincter of Oddi manometry in idiopathic recurrent pancreatitis. Gastrointest Endosc. 2002;55:157-62.
148. Parasher VK, Romain K, Sukumar R, et al. Can ERCP contrast agents cause pseudomicrolithiasis? Their effect on the final outcome of bile analysis in patients with suspected microlithiasis. Gastrointest Endosc. 2000;51:401-4.
149. Ponchon T, Pilleul F. Diagnostic ERCP. Endoscopy. 2002;34:29-42.
150. Blaut U, Sherman S, Fogel E, et al. Influence of cholangiography on biliary sphincter of Oddi manometric parameters. Gastrointest Endosc. 2000;52:624-9.
151. Sweeney JT, Ulrich CD. Genetics of pancreatic disease. Clin Perspect Gastroenterol. 2002;5:110-6.
152. Liu CL, Lo CM, Chan JK, et al. EUS for detection of occult cholelithiasis in patients with idiopathic pancreatitis. Gastrointest Endosc. 2000;51:28-32.
153. Rösch T, Dittler HJ, Fockens P, et al. Major complications of endoscopic ultrasonography: results of a survey of 42106 cases [Abstract]. Gastrointest Endosc. 1993;39:341.
154. Kohut M, Nowakowska-Dulawa E, Marek T, et al. Accuracy of linear endoscopic ultrasonography in the evaluation of patients with suspected common bile duct stones. Endoscopy. 2002;34:299-303.
155. Prat F, Edery J, Meduri B, et al. Early EUS of the bile duct before endoscopic sphincterotomy for acute biliary pancreatitis. Gastrointest Endosc. 2001;54:724-9.
156. Mertz HR, Sechopoulos P, Delbeke D, et al. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc. 2000;52:367-71.
157. Catalano MF, Lahoti S, Geenen JE, et al. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc. 1998;48:11-7.
158. Bhutani MS, Hoffman BJ, Hawes RH. Diagnosis of pancreas divisum by endoscopic ultrasonography. Endoscopy. 1999;31:167-9.
159. Sugiyama M, Atomi Y. Endoscopic ultrasonography for diagnosing anomalous pancreaticobiliary junction. Gastrointest Endosc. 1997;45:261-7.
160. Tio TL, Rohde P, Sie LH, et al. Endosonography in the pre-operative diagnosis of choledochocele. Gastrointest Endosc. 1992;38:381-3.
161. Gress F, Yiengpruksawan A, Sherman S, et al. Diagnosis of annular pancreas by endoscopic ultrasound. Gastrointest Endosc. 1996;44:485-9.
162. Soto JA, Barish MA, Yucel EK, et al. Pancreatic duct: MR cholangiopancreatography with a three-dimensional fast spin-echo technique. Radiology. 1995;196:459-64.
163. Bearcroft PW, Lomas DJ. Magnetic resonance cholangiopancreatography. Gut. 1997;41:135-7.
164. Coakley FV, Schwartz LH. Magnetic resonance cholangiopancreatography. J Magn Reson Imaging. 1999;9:157-62.
165. De Backer AI, Van den Abbeele K, De Schepper AM, et al. Choledochocele: diagnosis by magnetic resonance imaging. Abdom Imaging. 2000;25:508-10.
166. Taourel P, Bret PM, Reinhold C, et al. Anatomic variants of the biliary tree: diagnosis with MR cholangiopancreatography. Radiology. 1996;199:521-7.
167. Adamek HE, Weitz M, Breer H, et al. Value of magnetic-resonance cholangiopancreatography (MRCP) after unsuccessful endoscopic-retrograde cholangiopancreatography (ERCP). Endoscopy. 1997:29:741-4.
168. Chan YL, Chan AC, Lam WW, et al. Choledocholithiasis: comparison of MR cholangiography and endoscopic retrograde cholangiography. Radiology. 1996:200:85-9.
169. Baillie J. Magnetic resonance cholangiopancreatography: the gastroenterologist's perspective. Gastrointest Endosc. 2002;55(suppl 7):13-5.
170. Matos C, Metens T, Deviere J, et al. Pancreatic duct: morphologic and functional evaluation with dynamic MR pancreatography after secretin stimulation. Radiology. 1997;203:435-41.
171. Deviere J, Matos C, Cremer M. The impact of magnetic resonance cholangiopancreatography on ERCP. Gastrointest Endosc. 1999;50:136-40.
172. Manfredi R, Costamagna G, Brizi MG, et al. Pancreas divisum and 'santorinicele': diagnosis with dynamic MR cholangiopancreatography with secretin stimulation. Radiology. 2000;217:403-8.
173. Devereaux BM, Fogel EL, Aisen A, et al. Secretin-stimulated functional MRCP: correlation with sphincter of Oddi manometry [Abstract]. Gastrointest Endosc. 2000;51:197.